Summary of Study ST001907

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001201. The data can be accessed directly via it's Project DOI: 10.21228/M8G69Q This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001907
Study TitleTraining-induced bioenergetic improvement in human skeletal muscle is associated with non-stoichiometric changes in the mitochondrial proteome without reorganisation of respiratory chain content
Study TypeMulti Omics
Study SummaryLipidomic analysis of muscle mitochondrial isolates. 10 men with repeated measures.
Institute
Baker Heart and Diabetes Institute
DepartmentMeteabolomics
LaboratoryMeteabolomics
Last NameHuynh
First NameKevin
Address75 Commercial Road
Emailkevin.huynh@baker.edu.au
Phone0385321537
Submit Date2021-08-15
Num Groups1
Total Subjects10
Num Males10
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2021-10-18
Release Version1
Kevin Huynh Kevin Huynh
https://dx.doi.org/10.21228/M8G69Q
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001201
Project DOI:doi: 10.21228/M8G69Q
Project Title:Training-induced bioenergetic improvement in human skeletal muscle is associated with non-stoichiometric changes in the mitochondrial proteome without reorganisation of respiratory chain content
Project Type:Multi-omics
Project Summary:Defects in mitochondria have been implicated in multiple diseases and aging. Interventions to improve mitochondrial function have the potential to improve quality of life. Exercise training is a readily accessible and inexpensive intervention, however how it promotes mitochondrial adaptation in skeletal muscle remains poorly understood. Here, we describe an intricate and previously undemonstrated network of differentially prioritised training-induced adaptations in human skeletal muscle mitochondria. We show that changes in hundreds of transcripts, proteins and lipid species are not stoichiometrically linked to the increase in mitochondrial content. We demonstrate a prioritization of specific pathways at different stages of the intervention, including initial deprioritisation of oxidative phosphorylation (OXPHOS) and prioritisation of TCA cycle and fatty acid β-oxidation linked mitochondrial respiration. This indicates that enhancing electron flow to OXPHOS is more important to increase ATP production than increasing the abundance of the OXPHOS machinery. Our research unearths the elaborate and multi-layered nature of the adaptive response to exercise and provides a valuable resource that can be mined to maximise the therapeutic benefits of exercise.
Institute:Baker Heart and Diabetes Institute
Department:Baker Heart and Diabetes Institute
Laboratory:Metabolomics
Last Name:Huynh
First Name:Kevin
Address:75 Commercial Road
Email:kevin.huynh@baker.edu.au
Phone:0385321537

Subject:

Subject ID:SU001985
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Gender:Male

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id ID
SA17673410NK-10N
SA17673510NK-20N
SA17673610NK-80N
SA17673710NK-50N
SA17673812JP-82J
SA17673912JP-22J
SA17674012JP-12J
SA17674112JP-52J
SA17674213AP-13A
SA17674313AP-53A
SA17674413AP-83A
SA17674513AP-23A
SA17674614EP-84E
SA17674714EP-14E
SA17674814EP-24E
SA17674914EP-54E
SA1767501AM-2AM
SA1767511AM-5AM
SA1767521AM-1AM
SA1767531AM-8AM
SA1767545CP-2CP
SA1767555CP-1CP
SA1767565CP-8CP
SA1767575CP-5CP
SA1767589GG-1GG
SA1767599GG-2GG
SA1767609GG-5GG
SA1767619GG-8GG
SA1767627SL-8SL
SA1767637SL-1SL
SA1767647SL-5SL
SA1767657SL-2SL
SA1767664SR-2SR
SA1767674SR-8SR
SA1767684SR-1SR
SA1767694SR-5SR
SA1767706WP-2WP
SA1767716WP-8WP
SA1767726WP-1WP
SA1767736WP-5WP
Showing results 1 to 40 of 40

Collection:

Collection ID:CO001978
Collection Summary:Muscle biopsies. A biopsy needle with suction under local anaesthesia (1% xylocaine) was 688 used to obtain vastus lateralis muscle biopsies at rest at the following four time points: BL, 689 PN, PH and PR. After being cleaned of excess blood, connective and fat tissue muscle 690 biopsies were divided as follows: ~10 mg was immediately immersed in ~2 mL of ice-cold 691 BIOPS for measurements of mitochondrial respiration, whereas the remainder was promptly 692 frozen in liquid nitrogen and stored at -80°C for follow-up analyses.
Sample Type:Muscle

Treatment:

Treatment ID:TR001997
Treatment Summary:Training intervention. All training sessions were performed on an electronically braked cycle ergometer (Velotron, RacerMate, USA), following an 8-min warm up (see 20k-TT) and consisted of HIIT (2:1 work-to-rest ratio). Training intensity was set relative to ẆLT (rather than ẆPeak) so as to induce similar metabolic and cardiac stresses amongst participants of differing fitness levels75. Exercise intensity was maintained between ẆLT and ẆPeak throughout the entire study so that training volume was the only manipulated variable between the 3 phases. NVT phase. This consisted of 6 HIIT sessions within 2 weeks of 5 to 7 4-min cycling intervals interspersed with a 2-min recovery at 60 W. Exercise intensities were defined as [ẆLT + x(ẆPeak-ẆLT)], with x increasing from 0.5 to 0.7 throughout the phase. HVT phase. Participants performed HIIT twice a day for 20 consecutive days; training sessions consisted of either 7 to 10 4-min intervals interspersed with a 2-min recovery at 60 W at intensities ranging from [ẆLT + 0.5(ẆPeak-ẆLT)] to [ẆLT + 0.8(ẆPeak-ẆLT)], or 15 to 20 2-min intervals at intensities ranging from [ẆLT + 0.5(ẆPeak-ẆLT)] to [ẆLT + 0.95(ẆPeak-ẆLT)], interspersed with a 1-min recovery at 60 W. Single session duration increased from ~45 min to 60 min. RVT phase. The RVT phase consisted of 6 HIIT sessions in 6 days; participants performed 10, 9, 8, 7, 6, and 4, 4-min intervals interspersed with a 2-min recovery at 60 W, at an intensity of [ẆLT + x(ẆPeak- ẆLT)], with x increasing from 0.5 to 0.7 throughout the phase.

Sample Preparation:

Sampleprep ID:SP001991
Sampleprep Summary:Mitochondrial isolates were extracted using a modified single-phase chloroform/methanol extraction as described previously (Weir et al. 2013). In brief, 20 volumes of chloroform:methanol (2:1) were added to the sample along with a series of internal standards. Samples were vortexed and centrifuged on a rotary mixer for 10 min. Following sonication on a sonicator bath for 30 min, samples were rested for 20 min prior to centrifugation at 13,000 g for 10 min. Supernatants were transferred into a 96 well plated, dried down and reconstituted in 50 μL H2O saturated butanol and sonicated for 10 min. After the addition of 50 μL of methanol with 10 mM ammonium 945 formate, samples were centrifuged at 4000 rpm on a plate centrifuge and transferred into glass vials with inserts for mass spectrometry analysis.
Processing Storage Conditions:-80℃
Extraction Method:Single phase 2:1 chloroform methanol
Extract Storage:-80℃
Sample Resuspension:Butanol : Methanol 1:1
Subcellular Location:Mitochondria

Combined analysis:

Analysis ID AN003104
Analysis type MS
Chromatography type Reversed phase
Chromatography system Agilent 1290 Infinity II
Column Agilent Zorbax Eclipse Plus C18 (100 x 2.1mm, 1.8 um)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Agilent 6490 QQQ
Ion Mode POSITIVE
Units pmol per mg

Chromatography:

Chromatography ID:CH002291
Chromatography Summary:The running solvent consisted of solvent A: 50% H2O / 30% acetonitrile / 20% isopropanol (v/v/v) containing 10mM ammonium formate and 5uM medronic acid, and solvent B: 1% H2O / 9% acetonitrile / 90% isopropanol (v/v/v) containing 10mM ammonium formate. We utilized a stepped linear gradient with a 16-minute cycle time per sample and a 1µL sample injection. To increase throughput, we used a dual column set up to equilibrate the second column while the first is running a sample. The sample analytical gradient was as follows: starting with a flow rate of 0.4mL/minute at 15% B and increasing to 50% B over 2.5 minutes, then to 57% over 0.1 minutes, to 70% over 6.4 minutes, to 93% over 0.1 minute, to 96% over 1.9 minutes and finally to 100% over 0.1 minute. The solvent was then held at 100% B for 0.9 minutes (total 12.0 minutes). Equilibration was started as follows: solvent was decreased from 100% B to 15% B over 0.2 minutes and held until a total of 16 minutes. The next sample is injected and the columns are switched.
Instrument Name:Agilent 1290 Infinity II
Column Name:Agilent Zorbax Eclipse Plus C18 (100 x 2.1mm, 1.8 um)
Flow Gradient:starting with a flow rate of 0.4mL/minute at 15% B and increasing to 50% B over 2.5 minutes, then to 57% over 0.1 minutes, to 70% over 6.4 minutes, to 93% over 0.1 minute, to 96% over 1.9 minutes and finally to 100% over 0.1 minute. The solvent was then held at 100% B for 0.9 minutes (total 12.0 minutes). Equilibration was started as follows: solvent was decreased from 100% B to 15% B over 0.2 minutes and held until a total of 16 minutes.
Flow Rate:0.4mL/min
Solvent A:50% water/30% acetonitrile/20% isopropanol; 10mM ammonium formate; 5uM medronic acid
Solvent B:1% water/9% acetonitrile/90% isopropanol; 10mM ammonium formate
Chromatography Type:Reversed phase

MS:

MS ID:MS002886
Analysis ID:AN003104
Instrument Name:Agilent 6490 QQQ
Instrument Type:Triple quadrupole
MS Type:ESI
MS Comments:Details previously published in https://doi.org/10.1016/j.chembiol.2018.10.008
Ion Mode:POSITIVE
  logo